ENABLE (SHP643-402)

Category: Medical

ASO Keyword Dashboard

Tracking 2 keywords for ENABLE (SHP643-402) in Apple App Store

Developer: ERT,INC Category: medical

ENABLE (SHP643-402) tracks 2 keywords (2 keywords rank; full coverage across the tracked set). Key metrics: 50% top-10 coverage, opportunity 57.5, difficulty 46.9, best rank 2.

Tracked keywords

2 ranked • 0 not ranking yet

Top 10 coverage

50%

Best rank 2 • Latest leader 2

Avg opportunity

57.5

Top keyword: enable

Avg difficulty

46.9

Lower scores indicate easier wins

Opportunity leaders

enable

Opportunity: 58.0 • Difficulty: 52.8 • Rank 2

Competitors: 111
61.2
enables

Opportunity: 57.0 • Difficulty: 41.0 • Rank 30

Competitors: 45
56.5

Unranked opportunities

Every tracked keyword currently has some ranking data.

High competition keywords

enable

Total apps: 506 • Major competitors: 111

Latest rank: 2 • Difficulty: 52.8
enables

Total apps: 314 • Major competitors: 45

Latest rank: 30 • Difficulty: 41.0

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
enable	58	100	53	61 506 competing apps Median installs: 289,812 Avg rating: 4.6	2	2	111 major competitor apps
enables	57	100	41	56 314 competing apps Median installs: 194,700 Avg rating: 4.6	30	30	45 major competitor apps

Major Competitors

enable

100

506 competing apps

Median installs: 289,812

Avg rating: 4.6

111

major competitor apps

enables

100

314 competing apps

Median installs: 194,700

Avg rating: 4.6

major competitor apps

App Description

A three-year, non-interventional, prospective, multicenter study to evaluate the long-term effectiveness of lanadelumab in real-world clinical practice (ENABLE)